Accelerate Diagnostics Inc (MEX:AXDX)
MXN 24.91 0 (0%) Market Cap: 505.06 Mil Enterprise Value: 937.51 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Accelerate Diagnostics Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 07:30PM GMT
Release Date Price: MXN3618
Eleni Maria Apostolatos
JP Morgan Chase & Co, Research Division - Research Analyst

Hello, everyone. My name is Eleni, and I am on the Life Sciences team here at JPMorgan. It is my pleasure to introduce our next company, Accelerate Diagnostics. As a reminder, we will be hosting a breakout session in the Olympic room following the presentation.

And with that, I'm happy to turn it over to Jack.

Jack Phillips
Accelerate Diagnostics, Inc. - COO

Thank you, Eleni. Appreciate the introduction. As the incoming CEO for Accelerate Diagnostics, I'm very happy to be here today. Actually, what I want to do is start out by recognizing our founder and the CEO for the past 6 years, Larry Mehren, for your vision, for what you've accomplished in building such a great company and also the trust in me to lead it moving forward. Thank you very much. Really appreciate it.

What I want to start out today doing is I'm going to first talk a bit about why we're doing what we're doing, so the challenge within health care that we're working on solving. And I also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot